tiprankstipranks
Alterola Biotech (ABTI)
OTHER OTC:ABTI
US Market
ABTI
Alterola Biotech
RESEARCH TOOLSreports

Alterola Biotech (ABTI) Income Statement

10 Followers

Alterola Biotech Income Statement

Last quarter (Q2 2024), Alterola Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Alterola Biotech's net income was $-123.16K. See Alterola Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Sep 20Sep 19Sep 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.70M$ 6.47M$ 329.51K$ 258.45K$ 122.56K
Depreciation and Amortization
$ 200.00K$ 0.00$ 79.00K$ 206.30K$ 171.86K
EBITDA
$ -1.70M$ -6.47M$ -250.51K$ -258.45K$ -122.56K
Operating Income
$ -1.90M$ -6.47M$ -329.51K$ -258.45K$ -122.56K
Other Income/Expenses
$ 200.00K$ 0.00$ 79.00K$ -249.00$ -10.51K
Pretax Income
$ -1.70M$ -6.47M$ -250.51K$ -258.70K$ -133.07K
Net Income
$ -1.54M$ -6.47M$ -171.51K$ -258.70K$ -133.07K
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ 0.00$ 0.00$ >-0.01
Diluted EPS
$ 0.00$ -0.01$ 0.00$ 0.00$ >-0.01
Weighted Average Shares Outstanding
 806.33M 769.97M 118.06M 116.56M 115.62M
Weighted Average Shares Outstanding (Diluted)
 806.33M 769.97M 118.06M 116.56M 115.62M
Currency in USD

Alterola Biotech Earnings and Revenue History